Sichuan jiayinglai technology CO.,LTD
Firmenname:
Sichuan jiayinglai technology CO.,LTD
Telefon:
028-028-64159575
E-Mail:
1678230860@qq.com
Nationalität:
China
URL:
www.jiayinglai.com/
Produkte insgesamt:
2348
16
17
18
19
20
21
22
23
24
Produktkatalog
2-CHLORO-6-(TRIFLUOROMETHYL)PHENYL
16583-76-9
C8H3ClF3NO
2-Fluoro-4-Hydroxyaniline
1009816-75-4
C6H6FNO
4-CHLORO-N,N-DIMETHYL-PYRIDINE-2-CARBOXAMIDE
114780-06-2
C8H9ClN2O
RG-S1-XA; 4-Chloropyridine-2-carboxamide
99586-65-9
C6H5ClN2O
2-Pyridinecarboxamide,N-methyl-(9CI)
6144-78-1
C7H8N2O
2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL
51488-22-3
C8H3ClF3NO
RG-368;Regorafenib Impurity 10
2098799-12-1
C19H17FN4O3
Regorafenib impurity
2243399-56-4
C14H9ClF4N2O2
1-Bromo-2-methoxy-3-nitro-benzene
98775-19-0
C7H6BrNO3
D3-EZLA-M1
1802242-43-8
C21H15F4N3O3S
Levosimendan
36725-41-4
C11H11ClN2O
4-(Isopropylamino)-2-(trifluoromethyl)benzonitrile
864286-45-3
C11H11F3N2
2-HYDROXY-3''-NITRO-BIPHENYL-3-CARBOXYLIC ACID
376591-95-6
C13H9NO5
Benzamide, 4-[[[[4-cyano-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-2-fluoro-N-methyl-
1351185-73-3
C17H12F4N4O2
INDEX NAME NOT YET ASSIGNED
2518416-73-2
C22H12Cl2F7N3O3
[1,1'-Biphenyl]-3-carboxylic acid, 3'-[2-[1-(3,4-dimethylphenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]diazenyl]-2'-hydroxy-, 2-aminoethyl ester
2587607-84-7
C27H27N5O4
N-[4-(2-bromopropanoyl)phenyl]acetamide
63514-63-6
C11H12BrNO2
D3-EZLA-S1
1802242-47-2
C13H16FNO4
EZLA-API
915087-16-0
C21H17F3N4O2S
S2-Z01
2500321-37-7
C14H18N2O
Carbamothioic acid, N-[4-cyano-3-(trifluoromethyl)phenyl]-, O-ethyl ester
2088914-59-2
C11H9F3N2OS
EZ-396
1798807-39-2
C17H12F4N4OS
4-CYANO-3-(TRIFLUOROMETHYL)ACETANILIDE
97760-99-1
C10H7F3N2O
EZ-422
1289942-55-7
C20H18F4N4O2
AI-ZA04;4-Chloro-alpha,alpha,alpha-trifluoro-m-toluidine
4-Chlor-α,α,α-trifluor-m-toluidin
320-51-4
C7H5ClF3N
Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate
2206827-14-5
C17H19N3O4
NA
1489977-24-8
D3-EZ-S2
143782-23-4
C9H3F3N2S
2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid
376591-94-5
C14H11NO5
EZLA:S3-2J-S
1839619-50-9
C17H8F6N4S
1437383-35-1
1437383-35-1
C26H24N4O4
Propanedinitrile, 2-[2-[4-(1,6-dihydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazinylidene]-
131741-36-1
C14H10N6O
(R)-6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
101328-85-2
C11H13N3O
API-ZA02/RG-L;API-ZA02/RG-L(EZLA-S3-2J-O); FLUCOFURON
1,3-Bis(4-chlor-alpha,alpha,alpha-trifluor-m-tolyl)harnstoff
370-50-3
C15H8Cl2F6N2O
EZLA-API-ZZA
1895865-10-7
C10H7F3N2OS
RG-491; INDEX NAME NOT YET ASSIGNED
2518234-85-8
C25H19F2N5O4
SL-CLYG;Sorafenib related coMpound 8
1431697-81-2
C21H16ClF3N4O3
Sorafenib impurity N/1-(4-chloro-3-(trifluoromethyl)phenyl)urea
343247-69-8
C8H6ClF3N2O
AQ-M1-JM
1176777-76-6
C14H13NO3
Benzamide, N-[[[4-cyano-3-(trifluoromethyl)phenyl]amino]thioxomethyl]-
1895865-08-3
C16H10F3N3OS
Levosimendan Impurity 14
144238-75-5
C14H12N6O
4-Amino-2-(trifluoromethyl)benzonitrile
654-70-6
C8H5F3N2
(S)-3(2h)-Pyridazinone, 6-(4-Aminophenyl)-4,5-Dihydro-5-Methyl-
101328-84-1
C11H13N3O
2-(1-(4-acetaMidophenyl)-1-oxopropan-2-yl)Malonic acid
1221499-54-2
C14H15NO6
Enzalutamide Impurity 7
2030242-21-6
C21H18F4N4O3S
EZLA-2JXA
1443331-78-9
C22H18F4N4O2S
API-ZA07;3,4-BIS CTF- CARBOMYLAMINE PMA REGORAFENIB
2098799-13-2
C35H23Cl2F7N6O5
Levosimendan
141505-33-1
C14H12N6O
Regorafenib;BAY 73-4506
755037-03-7
C21H15ClF4N4O3
SL-M2-2J;Sorafenib Impurity 3
284670-98-0
C27H24N6O5
Levosimendan Impurity 16
2290570-69-1
C11H12N2O
Sorafenib Impurity 6
2204442-52-2
C27H23N5O6
API-ZA01/M2-2J
2438857-80-6
C27H22F2N6O5
Methyl 4-bromo-2-fluorobenzoate
179232-29-2
C8H6BrFO2
2-fluoro-N,N-dimethyl-4-nitro-benzamide
1187368-66-6
C9H9FN2O3
2-fluoro-4-hydroxy-N-methylbenzamide
1243392-80-4
C8H8FNO2
API-ZA05/API-ZA05/RG-F
2188236-16-8
C21H16F4N4O3
SM1-ZA01
348-90-3
C9H7ClF3NO
6-Chloro-N-methylpyridine-2-carboxamide
845306-04-9
C7H7ClN2O
Levosimendan Impurity 10
134678-47-0
C11H12N2O2
3-(2-Hydroxyphenyl)benzoic acid
893736-72-6
C13H10O3
Levosimendan-001
244077-42-7
C11H14N4O
6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone
36725-28-7
C11H13N3O
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide
835621-11-9
C21H15ClF4N4O4
Regorafenib impurity H
2141961-84-2
C15H14FN3O3
D3-EZLA-IM2
1242137-16-1
C20H14F4N4O2S
D3-EZLA-M2
1242137-15-0
C20H13F4N3O3S
Sorafenib Impurity 6
1285533-84-7
C21H17F3N4O3
4-(4-acetamidophenyl)-3-methyl-4-oxobutanoic acid
36725-26-5
C13H15NO4
N-Desmethyl Regorafenib N-Oxide (M5 Metabolite)
835621-12-0
C20H13ClF4N4O4
M2-ZA05
376592-56-2
C25H21ClN4O4
diethyl 2-(1-(4-acetaMidophenyl)-1-oxopropan-2-yl)Malonate
81937-39-5
C18H23NO6
EZ-437
2463603-98-5
C21H19F4N3O3
Regorafenib Impurities67
2514957-39-0
C16H16FN3O4
Methyl (4-chloro-3-trifluoromethylphenyl)carbamate
19448-54-5
C9H7ClF3NO2
LevosiMendan iMpurity
139052-02-1
Levosimendan Impurity 8
274263-65-9
C14H14N6O2
EZLA-ZZC-0/EZLA-S1
749927-69-3
C8H7BrFNO
ETHYL 4-CHLORO-3-TRIFLUOROMETHYLCARBANILATE
18585-06-3
C10H9ClF3NO2
4-((2-carboxypropan-2-yl)amino)-2-fluorobenzoic acid| (API-ZZJ)
1332524-02-3
C11H12FNO4
4-(4-Aminophenyl)-3-methyl-4-oxobutanoic acid
42075-29-6
C11H13NO3
Oxo Enzalutamide
1242137-18-3
C21H16F4N4O3
TICAGRELOR
1129683-88-0
C14H14N4O3
EZ-S3-2J-O
1895865-11-8
C17H8F6N4O
SM3-ZA02/RG-D;Regorafenib iMpurity
1333390-56-9
C14H9ClF4N2O2
3(2H)-Pyridazinone, 6-(4-chlorophenyl)-4,5-dihydro-5-methyl-, (5R)-
1630760-90-5
C11H11ClN2O
SORAFENIB N-OXIDE
583840-03-3
C21H16ClF3N4O4
4-amino-2-fluoro-N-methylbenzamide
915087-25-1
C8H9FN2O
3(2H)-Pyridazinone, 4,5-dihydro-5-methyl-6-phenyl-, (5R)-
1630760-89-2
C11H12N2O
N-[4-(AMinocarbonyl)-3-fluorophenyl]-2-Methylalanine
1242137-20-7
C11H13FN2O3
NA
4-(4-AMINO-3-FLUOROPHENOXY)-N-METHYLPICOLINAMIDE
757251-39-1
C13H12FN3O2
Levosimendan Impurity 4
131741-37-2
C14 H14 N6 O2
EZLA-M1
1289942-66-0
C12H15FN2O3
4-Bromo-2-fluorobenzoic acid
112704-79-7
C7H4BrFO2
Enzalutamide
915087-33-1
C21H16F4N4O2S
Levosimendan Impurity 2
103416-88-2
C11H12N2O2
Thiourea, N-[4-cyano-3-(trifluoromethyl)phenyl]-
1415552-04-3
C9H6F3N3S
16
17
18
19
20
21
22
23
24
Copyright 2019 © ChemicalBook. All rights reserved